Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0XT1M
|
|||
Former ID |
DIB009391
|
|||
Drug Name |
Valrocemide
|
|||
Synonyms |
N-Valproylglycinamide; TV-1901; TVP-1901; Valrocemide < Prop INN
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Discontinued in Phase 2 | [1] | |
Company |
Teva Pharmaceutical Industries
|
|||
Structure |
Download2D MOL |
|||
Formula |
C10H20N2O2
|
|||
Canonical SMILES |
CCCC(CCC)C(=O)NCC(=O)N
|
|||
InChI |
1S/C10H20N2O2/c1-3-5-8(6-4-2)10(14)12-7-9(11)13/h8H,3-7H2,1-2H3,(H2,11,13)(H,12,14)
|
|||
InChIKey |
RALGCAOVRLYSMA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 92262-58-3
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010331) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.